(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA), today, is announcing a new ad campaign, “Drug Manufacturers are Pointing Fingers…Again.”

With Congress poised to permanently repeal the rebate rule and prevent significant increases in both Medicare beneficiary premiums and Medicare Part D program costs, the pharmaceutical industry is promoting policies that would undo this progress and increase premiums for Medicare beneficiaries.

Click here to see the new ad “Drug Manufacturers are Pointing Fingers…Again.”

“We urge lawmakers to resist policies that would not only fail to achieve Congress’ stated goal of reducing prescription drug costs, but that would raise premiums on seniors,” said JC Scott, PCMA President and CEO. “Rather than the finger pointing coming from the pharmaceutical industry, we should be working together on common solutions to lower costs for patients.”

PBMs have proposed multiple solutions that will work for taxpayers and patients. For more information view The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access.

A recently released study by Visante examines the strategies brand pharmaceutical manufacturers use to maintain high prices.

For America’s pharmacy benefit managers, PBMs, the core mission is to increase access to affordable prescription drugs for all Americans.

Click here to see a new infographic, “PCMA Supports Straightforward Solutions to Reduce Drug Costs.”

###

PCMA is the national association representing America’s pharmacy benefit managers (PBMs).  PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including:  commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.